The global radiotherapy market is undergoing a technological renaissance, with new data projecting the sector will grow from USD 7.21 billion in 2024 to USD 9.62 billion by 2030. According to the latest industry analysis, this represents a steady compound annual growth rate (CAGR) of 4.9%, fueled by a rising global cancer burden and a paradigm shift toward high-precision treatment modalities.
The market landscape is increasingly defined by the transition from traditional photon therapy to advanced External Beam Radiotherapy (EBRT), including Proton and Particle therapy. These technologies allow for higher dose escalation with minimal damage to surrounding healthy tissue, addressing a critical need for patients who have reached the limits of conventional radiation.
Key Market Highlights:
-
Technological Leadership: AI-powered, adaptive CT-Linac systems are becoming the new gold standard, allowing for real-time adjustments to treatment plans based on daily anatomical changes in patients.
-
Segment Dominance: The Hospital segment continues to lead the market, driven by heavy investments in multi-disciplinary cancer care infrastructure and the integration of radiotherapy with immunotherapy.
-
Regional Growth: While North America remains the largest market due to favorable reimbursement models, the Asia Pacific region is slated for the highest growth, spurred by rapid healthcare expansion in China and India.
-
Strategic Consolidation: Key industry players, including Siemens Healthineers, Elekta, and Accuray, are focusing on “Value-Based Care” models to align with new government payment structures in the U.S. and Europe.
Despite challenges such as the high capital cost of equipment and a global shortage of trained medical physicists, the market is bolstered by a wave of new regulatory approvals for compact, “plug-and-play” radiotherapy systems designed for smaller clinical settings.
Detailed insights into technology trends, procedure types, and regional competitive analysis are available in the full Radiotherapy Market Report.